These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12060388)

  • 1. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.
    Dereure O; Levi E; Vonderheid EC; Kadin ME
    J Invest Dermatol; 2002 Jun; 118(6):949-56. PubMed ID: 12060388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
    Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
    Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.
    Shin MS; Park WS; Kim SY; Kim HS; Kang SJ; Song KY; Park JY; Dong SM; Pi JH; Oh RR; Lee JY; Yoo NJ; Lee SH
    Am J Pathol; 1999 Jun; 154(6):1785-91. PubMed ID: 10362803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions.
    Nagasawa T; Takakuwa T; Takayama H; Dong Z; Miyagawa S; Itami S; Yoshikawa K; Aozasa K
    Oncology; 2004; 67(2):130-4. PubMed ID: 15539917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas.
    McGregor JM; Crook T; Fraser-Andrews EA; Rozycka M; Crossland S; Brooks L; Whittaker SJ
    J Invest Dermatol; 1999 Mar; 112(3):317-21. PubMed ID: 10084308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells.
    Unger C; Buchmann A; Bünemann CL; Kress S; Schwarz M
    Cell Death Differ; 1998 Jan; 5(1):87-95. PubMed ID: 10200449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.
    Li G; Chooback L; Wolfe JT; Rook AH; Felix CA; Lessin SR; Salhany KE
    J Invest Dermatol; 1998 May; 110(5):767-70. PubMed ID: 9579543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
    Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
    Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
    Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
    Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.
    Kobayashi T; Ruan S; Jabbur JR; Consoli U; Clodi K; Shiku H; Owen-Schaub LB; Andreeff M; Reed JC; Zhang W
    Cell Death Differ; 1998 Jul; 5(7):584-91. PubMed ID: 10200513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
    Bariş YS; Yildiz L; Sentürk N; Kandemir B
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy.
    Aydin F; Levent Y; Nilgun S; Pancar YE; Yasar TA
    Indian J Dermatol; 2011; 56(5):501-4. PubMed ID: 22121263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.